Name
Dealmaking, pipelines, and regulatory risk – the current life sciences M&A landscape
Date & Time
Wednesday, October 21, 2026, 9:45 AM - 10:45 AM
Speakers
Kristin Sanford, Weil, Gotshal & Manges
David Gonen, Katten Muchin Rosenman
Elizabeth Porfido, Pfizer
Meghan Rissmiller, Freshfields
Paul Wong, NERA
Kristin Sanford David Gonen Elizabeth Porfido Meghan Rissmiller Paul Wong
Description
  • The resurgence of life sciences dealmaking in 2026, and the drivers behind renewed M&A activity
  • Agency scrutiny of transactions involving pipeline products and future competition
  • What the shift from transformative “megadeals” to targeted acquisitions of specialised firms means for the future of M&A deals
Session Type
Panel